Recent advances from COVID-19 vaccine development put pharma in place to further grow relationship with patients.
Vijesh Unnikrishnan
Advertisement
Principal, ZS
Articles by Vijesh Unnikrishnan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Most Important Lessons Learned from Building CGT Supply Chains: LogiPharma 2026
2
Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing
3
Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
4
FDA Approves Tecentriq for Stage III dMMR Colon Cancer
5